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MaOBJECTIVES The aim of this study was to deﬁne the morphological features of coronary artery spasm sites using
optical coherence tomography (OCT) in patients with vasospastic angina (VSA).
BACKGROUND Plaque characteristics at coronary artery spasm sites have not been investigated systematically.
METHODS Sixty-nine consecutive patients (80 spasm sites) presenting with VSA who underwent OCT imaging were
included in this study. Fibrous cap disruptionwas identiﬁed by the discontinuation ofﬁbrous capwith orwithout intraplaque
cavity formation. OCT-deﬁned erosion was established by the presence of thrombus with or without lumen irregularity
overlying an intact ﬁbrous cap on multiple adjacent OCT frames. Other morphological features such as the absence of
thrombus with or without lumen irregularity and those not in the previously mentioned criteria were also documented.
RESULTS Plaque was seen on OCT in 79 of the 80 spasm sites. Fibrous cap disruption was detected at 3 sites (4%).
OCT-deﬁned erosion was observed at 21 spasm sites (26%). Thrombus with lumen irregularity was observed in 20 sites,
whereas 1 site had thrombus without lumen irregularity. Lumen irregularity without thrombus was observed at 49
spasm sites (61%). Spontaneous spasm was seen more frequently in patients with acute myocardial infarction and
out-of-hospital cardiac arrest than in patients without these conditions (50.0% vs. 19.3%, p ¼ 0.025).
CONCLUSIONS Our results show that OCT-deﬁned erosion at spasm sites occurred in more than one-fourth of patients
in this study. Luminal irregularity was observed in nearly two-thirds of the patients without overlying thrombus. These
ﬁndings suggest the potential role of antiplatelet therapy in VSA. (J Am Coll Cardiol Img 2015;8:1059–67) © 2015 by the
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ABBR EV I A T I ON S
AND ACRONYMS
ACS = acute coronary
syndrome
AMI = acute myocardial
infarction
ECG = electrocardiogram
OCT = optical coherence
tomography
OHCA = out-of-hospital
cardiac arrest
TCFA = thin-cap ﬁbroatheroma
VSA = vasospastic angina
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1060blood stagnation caused by vasospasm could
contribute to intimal injury and thrombosis
(9). Although unable to visualize microscopic
detail of defects, angioscopic ﬁndings have
revealed evidence of intimal injury (hemor-
rhage, ﬂap, thrombus, or ulceration) at the
site of coronary artery spasm in patients
with VSA (10). Atherosclerotic plaques at the
spasm sites, however, have not been studied
extensively. Optical coherence tomography
(OCT) is a validated high-resolution imaging
modality that has the ability to assess the
ﬁbrous cap, thrombus, and lumen irregular-ity associated with atherosclerotic plaque (11,12).
The aim of this study was to evaluate the in vivo
morphological characteristics of coronary artery
spasm sites using OCT in patients with VSA.SEE PAGE 1068METHODS
STUDY POPULATION. This study was conducted at
2 teaching hospitals (Ulsan University Hospital,
Ulsan, South Korea, and Keimyung University
Dongsan Medical Center, Daegu, South Korea). Pa-
tients were enrolled between October 2011 and July
2012. Consecutive patients diagnosed with VSA were
included in this study. To diagnose VSA, the
following 2 criteria were used (13): 1) spontaneous or
ergonovine-induced coronary artery spasm (produc-
ing >90% narrowing of coronary lumen diameter by
angiography) associated with chest pain and ischemic
ST-segment changes (transient ST-segment elevation
or depression $0.1 mV, recorded on at least 2
contiguous leads on the 12-lead electrocardiogram
[ECG]); and 2) normal or insigniﬁcant coronary artery
disease (diameter stenosis <50%) after intracoronary
nitroglycerin injection.
Calcium-channel blockers and nitrates were
stopped for at least 48 h before the ergonovine prov-
ocation test in elective patients. All patients were
prescribed a loading dose of aspirin 200 mg and clo-
pidogrel 300mg. Unfractionated heparin 100 U/kg was
injected intravenously to maintain an activated clot-
ting time $250 s during the procedure. After baseline
angiography of the left and right coronary arteries, the
operator proceeded with the ergonovine provocation
test if there was no signiﬁcant angiographic stenosis
seen on multiple angiographic projections (deﬁned
as <50% diameter stenosis by visual estimation).
Intracoronary ergonovine was used in the left and
right coronary arteries, respectively, at incremental
doses of 20, 40, and 60 mg with 2-min intervalsbetween doses (13). If angiographic ﬁndings showed
focal luminal narrowing of more than 90% with chest
pain and ECG changes (ST-segment elevation or
depression $0.1 mV on at least 2 contiguous leads),
200 mg of intracoronary nitroglycerin was used to
conﬁrm spontaneous coronary vasospasm (13).
We excluded patients who had ﬁxed stenosis
($50% of the lumen diameter) in the spasm site;
comorbidities such as congestive heart failure, car-
diomyopathy, or chronic kidney disease; or past his-
tory of fatal arrhythmias, prior myocardial infarction,
or cardiogenic shock. This study was approved by the
institutional review board ethics committees at
participating centers, and written informed consent
was obtained from all participants.
OCT IMAGE ACQUISITION. OCT was performed at the
spasm site after administration of 200 mg of intra-
coronary nitroglycerin, and images were acquired
with a commercially available frequency-domain
OCT system and optic catheter (C7XR and Dragon
Fly catheter, LightLab Imaging/St. Jude Medical,
Westford, Massachusetts). A 2.7-F OCT imaging
catheter was advanced carefully distal to the spasm
site along a 0.014-inch guidewire. Automated pull-
back was performed at 20 mm/s while blood was
displaced by a short injection of contrast media
through the guiding catheter. Images were digitally
stored for off-line analysis.
OCT IMAGE ANALYSIS. All OCT images of culprit
vessels were analyzed at 0.5-mm intervals, including
spasm segments, by 2 independent investigators
(S.H.A. and A.-Y.H.) who were blinded to the clinical
presentations. When there was discordance between
the observers, a consensus reading was obtained from
a third investigator (E.-S.S.).
DEFINITION AND CLASSIFICATION OF SPASM SITES
BY OCT. OCT images were analyzed at spasm sites
that extended 5 mm proximally and distally from the
maximal spasm segments. This was conﬁrmed by an
independent, blinded investigator (Eok Rae Cho)
with the corresponding coronary angiography using
side branches as markers. The OCT-deﬁned morpho-
logical characteristics of spasm sites are shown in
Figure 1. The presence of plaque at the spasm site is
deﬁned in this study as intimal thickening $500 mm
observed with OCT. Fibrous cap disruption was
identiﬁed by discontinuation of the ﬁbrous cap
with or without intraplaque cavity formation (14).
OCT-deﬁned erosion was identiﬁed by the presence
of thrombus with or without lumen irregularity
overlying an intact ﬁbrous cap on multiple adjacent
OCT frames. Other morphological features such as
the absence of thrombus with or without lumen
FIGURE 1 OCT-Deﬁned Morphological Characteristics of Spasm Sites in
Vasospastic Angina
Underlying Plaque
Thrombus
Lumen IrregularityOCT-defined Erosion (n = 21)
n = 3
n = 49 n = 6
Fibrous Cap Disruption
Yes No
oNseY
Yes No
Yes No
Thrombus
n = 0 n = 1
Yes No
Observation of optical coherence tomography (OCT) images followed the sequence shown:
identiﬁcation of plaque at spasm sites, ﬁbrous cap disruption, presence of thrombus, and
lumen irregularity.
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1061irregularity and those not mentioned in the previ-
ously mentioned criteria were also documented.
Thrombus was deﬁned as a ﬂoating or protruding
mass into the lumen of a dimension >200 mm and was
categorized as either erythrocyte-rich (red) thrombus,
deﬁned by high backscattering and high attenuation,
or platelet-rich (white) thrombus, deﬁned by homo-
geneous backscattering with low attenuation (15). The
largest thrombus visualized was measured for area
size and maximal and minimal diameter.
Tissue characteristics of underlying plaque were
deﬁned by use of previously established criteria (12).
Plaques were classiﬁed as: 1) ﬁbrous (homogeneous,
high-backscattering region); or 2) lipid (low-signal
region with diffuse border). The presence of $1
quadrant of a region with low backscattering and poor
delineation was deﬁned as lipid-laden plaque, and
those with a thin cap (<65 mm) were deﬁned as thin-
cap ﬁbroatheroma (TCFA).
Interobserver variability was assessed by the
evaluation of 31% of the random images by 2 inde-
pendent observers. Intraobserver variability was
assessed at 2-week intervals by the evaluation of one-
third of the random images by an independent
investigator. The interobserver kappa coefﬁcients for
plaque disruption, lumen irregularity, thrombus, and
plaque classiﬁcation were 1.000, 0.834, 0.918, and
0.913, respectively. The intraobserver kappa co-
efﬁcients for plaque disruption, lumen irregularity,
thrombus, and plaque classiﬁcation were 1.000,
1.000, 0.918, and 0.940, respectively.
QUANTITATIVE CORONARY ANGIOGRAPHY. Coro-
nary angiography results were analyzed with the Car-
diovascular Angiography Analysis System (CAAS 5.10,
PieMedical Imaging B.V., Maastricht, the Netherlands)
by another independent investigator (Jeong Hoon
Jang) who was blinded to the OCT analysis. The refer-
ence diameter, minimum lumen diameter, diameter
stenosis, and spasm site length were measured.
CLINICAL MANIFESTATIONS. Clinical presentations
were recorded as out-of-hospital cardiac arrest
(OHCA) and AMI according to the American Heart
Association guidelines (16). AMI was diagnosed as the
typical rise and fall of cardiac injury markers (serum
troponin elevation above the 99th percentile of
normal), sudden onset of resting chest pain lasting
>20 min, or new ischemic changes on ECG. Venous
blood samples for creatinine kinase myocardial band
and troponin T were obtained from all patients before
coronary angiography and at 8-h intervals post-
angiography for 24 h.
STATISTICAL ANALYSIS. All statistical analyses were
performed with SPSS version 18.0 (SPSS Inc., Chicago,Illinois). Categorical variables were described as
counts and proportions, and the comparisons were
performed with the chi-square test or Fisher
exact test. Continuous variables were presented as
mean  SD or medians with interquartile ranges. The
differences in means of continuous measurements
were examined with the Student t test and nonpara-
metric Mann-Whitney U test for 2-group compari-
sons. There were no adjustments made for multiple
variables within individuals. All p values were
2-sided analyses with a statistical signiﬁcance level
of <0.05.
RESULTS
CLINICAL CHARACTERISTICS. Sixty-nine patients
were included during the study period; their clinical
characteristics are summarized in Table 1 (Online
Figure 1). The mean age was 54.4  8.0 years, and
73.9% were men. Six patients had multivessel spasm,
and 2 patients had multifocal spasm in the left ante-
rior descending artery and the right coronary artery.
Clinical manifestation of AMI/OHCA at admission was
observed in 17.4% (n ¼ 12). There were 52 patients
diagnosed with VSA by ergonovine provocation
test; no cases of fatal arrhythmia were documented
during the test. Spontaneous spasm was observed in
17 patients, which was more frequent in the AMI/
OHCA than the non-AMI/OHCA group (50% vs. 19.3%;
TABLE 1 Patient Characteristics
Total Population
(N ¼ 69)
AMI/OHCA
(n ¼ 12)
Non-AMI/OHCA
(n ¼ 57) p Value
Male 51 (73.9) 9 (75.0) 42 (73.7) 1.000
Age, yrs 54 (49–59) 54 (50–58) 54 (47–59) 0.962
BMI, kg/m2 24.3 (22.9–26.2) 26.0 (20.3–27.6) 24.3 (22.9–25.9) 0.716
Risk factors
Diabetes 6 (8.7) 2 (16.7) 4 (7.0) 0.278
Hypercholesterolemia 23 (33.3) 1 (8.3) 22 (38.6) 0.050
Smoking 0.243
Ex-smoker 12 (17.4) 1 (8.3) 11 (19.3)
Current smoker 31 (44.9) 8 (66.7) 23 (40.4)
Hypertension 25 (36.2) 5 (41.7) 20 (35.1) 0.667
Family history of CAD 2 (2.9) 1 (8.3) 1 (1.8) 0.320
Previous MI 1 (1.4) 0 (0) 1 (1.8) 1.000
Previous stroke 1 (1.4) 0 (0) 1 (1.8) 1.000
Clinical manifestation
Spontaneous spasm 17 (24.6) 6 (50.0) 11 (19.3) 0.025
OHCA 4 (5.8) 4 (33.3) 0 (0)
AMI 11 (15.9) 11 (91.7) 0 (0)
UA 58 (84.1) —
Braunwald class IB 7 (12.1) — 7 (12.3)
Braunwald class IIB 25 (43.1) — 25 (43.9)
Braunwald class IIIB 26 (44.8) — 25 (43.9)
ECG at admission <0.001
ST-segment elevation 12 (17.4) 8 (66.7) 4 (7.0)
ST-segment depression 1 (1.4) 0 (0) 1 (1.8)
T inversion 2 (2.9) 0 (0) 2 (3.5)
Laboratory ﬁndings
Creatinine, mg/dl 1.1 (0.9–1.2) 1.1 (0.9–1.4) 1.0 (0.9–1.2) 0.021
Total cholesterol, mg/dl 182 (154–207) 161 (136–162) 182 (157–205) 0.383
LDL, mg/dl 93 (77–117) 89 (51–58) 93 (77–124) 0.514
hs-CRP, m/dl 0.06 (0.03–0.16) 0.31 (0.09–0.75) 0.06 (0.03–0.13) 0.021
Peak CK-MB, ng/ml 1.1 (0.7–2.3) 10.6 (4.6–76.7) 0.9 (0.6–1.3) <0.001
Peak troponin T, ng/ml 0.01 (0.01–0.05) 1.03 (0.26–3.37) 0.01 (0.01–0.03) <0.001
Echocardiography
Ejection fraction, % 66 (62–69) 63 (51–68) 66 (62–69) <0.001
Spasm site (n ¼ 80) 0.919
LAD 35 (43.8) 7 (43.8) 28 (43.8)
LCx 7 (8.8) 1 (6.3) 6 (9.4)
RCA 38 (47.5) 8 (50.0) 30 (46.9)
Values are n (%) or median (interquartile range).
AMI ¼ acute myocardial infarction; BMI ¼ body mass index; CAD¼ coronary artery disease; CK-MB¼ creatinine
kinase, myocardial band; ECG ¼ electrocardiogram; hs-CRP ¼ high-sensitivity C-reactive protein; LAD ¼ left
anterior descending coronary artery; LCx¼ left circumﬂex artery; LDL¼ low-density lipoprotein; MI¼myocardial
infarction; OHCA ¼ out-of-hospital cardiac arrest; RCA ¼ right coronary artery; UA ¼ unstable angina.
Shin et al. J A C C : C A R D I O V A S C U L A R I M A G I N G , V O L . 8 , N O . 9 , 2 0 1 5
OCT Findings in Vasospastic Angina S E P T E M B E R 2 0 1 5 : 1 0 5 9 – 6 7
1062p ¼ 0.025). Admission ECG showing ST-segment
elevation was present in 8 patients (66.7%) in the
AMI/OHCA group and 4 (7.0%) in the non-AMI/OHCA
group (p < 0.01) (Table 1).
Coronary spasm was detected most frequently in
the right coronary artery (47.5%), followed by the left
anterior descending coronary artery (43.8%). The
minimal lumen diameter after intracoronary nitrate
injection was comparable between the 2 groups
(AMI/OHCA vs. non-AMI/OHCA, 2.34  0.66 mm vs.2.35  0.74 mm; p ¼ 0.945). Forty spasm sites (50.0%)
showed slow coronary ﬂow (TIMI [Thrombolysis In
Myocardial Infarction] ﬂow grade 0 to 2) during
coronary artery spasm. There was no statistically
signiﬁcant difference in the proportion of patients
with slow coronary ﬂow between the AMI/OHCA and
non-AMI/OHCA groups (31.3% vs. 54.7%; p ¼ 0.094).
Five patients (7.2%) had to have stents implanted
because of low fractional ﬂow reserve values (<0.75)
after nitroglycerin injection.
OCT FINDINGS. OCT ﬁndings are presented in
Figure 2 and Table 2. A representative case of
OCT-deﬁned erosion is demonstrated in Figure 3.
Thrombus was identiﬁed in 23 of 80 spasm sites
(28.8%). According to the OCT-deﬁned characteristics
in Figure 1, 3 spasm sites (4%) were classiﬁed as
ﬁbrous cap disruption, and 21 spasm sites (26%) with
intact ﬁbrous cap and thrombus were classiﬁed as
OCT-deﬁned erosion. Of the remaining spasm sites,
there were 49 (61%) with luminal irregularity in the
absence of thrombus (Online Figure 2), 6 (7.5%)
without thrombus or luminal irregularity, and 1
(1.25%) without plaque or thrombus. Among the 3
ﬁbrous cap disruption cases, 2 were the culprits
of AMI. Three of 4 patients who presented with
OHCA had AMI with spasm sites that demonstrated
OCT-deﬁned erosion; the remaining OHCA patient
had a spasm site that demonstrated luminal irregu-
larity in the absence of thrombus. Among the OCT-
deﬁned erosion spasm sites, there was 1 spasm
site that showed thrombus without lumen irregular-
ity. One patient who presented as having an
AMI had multiple spasm sites on the left anterior
descending coronary artery and right coronary artery.
Table 2 shows the OCT ﬁndings in ﬁbrous cap
disruption and OCT-deﬁned erosion groups. White
thrombus was predominantly detected, being ob-
served at 82.6% of spasm sites, compared with
red thrombus, which was seen at 17.4% of sites.
Thrombus was mainly located at the spasm sites
rather than proximal to the spasm sites. Both ﬁbrous
and lipid plaques were detected at spasm sites
(Table 2). TCFA was rarely seen (2 spasm sites
[2.5%]) and was only observed at OCT-deﬁned erosion
sites. The mean cap thickness of lipid plaques was
146  67 mm.
CLINICAL MANIFESTATIONS IN PATIENTS WITH
THROMBUS. The characteristics of spasm sites with
thrombus (ﬁbrous cap disruption and OCT-deﬁned
erosion) in 24 patients are listed in Table 3. These
thrombotic lesions were detected in 50.0% of the
AMI/OHCA group (6 of 12 patients) and 31.6% of the
non-AMI/OHCA group (18 of 57 patients; p ¼ 0.22);
FIGURE 2 Characteristics of Spasm Sites as Assessed by OCT in Patients With Vasospastic Angina
Each panel depicts the speciﬁc optical coherence tomography (OCT)–deﬁned characteristics and ﬁndings.
TABLE 2 OCT Findings at Spasm Sites
Total
Spasm Sites
(n ¼ 80)
Fibrous Cap
Disruption
(n ¼ 3)
OCT-Deﬁned
Erosion
(n ¼ 21)
Thrombus 23 (28.8)
Characteristics
Red thrombus 4 (17.4) 0 (0) 4 (19.0)
White thrombus 19 (82.6) 2 (100.0) 17 (81.0)
Location
Proximal to spasm site 4 (17.4) 0 (0) 4 (19.0)
At spasm site 19 (82.6) 2 (100.0) 17 (81.0)
Size
Area of thrombus, mm2 0.29  0.56 0.08  0.09 0.31  0.58
Maximal diameter, mm 0.64  0.55 0.28  0.18 0.68  0.56
Plaque
Fibrous plaque 35 (43.8) 1 (33.3) 10 (47.6)
Lipid plaque 45 (56.3) 2 (66.7) 11 (52.4)
TCFA, <65 mm 2 (4.4) 0 (0) 2 (18.2)
Cap thickness, mm 146.4  67.2 130.0  42.4 146.4  95.4
Values are n (%) or mean  SD.
OCT ¼ optical coherence tomography; TCFA ¼ thin-cap ﬁbroatheroma.
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1063patients with severe clinical presentation (AMI/
OHCA group) showed a trend toward more throm-
botic spasm sites, but this did not attain statistical
signiﬁcance. VSA was diagnosed spontaneously
(without provocation) in 41.7% and provocatively
in 25.0% of these thrombotic lesions (p ¼ 0.136).
There was no signiﬁcant difference in thrombus
size between the AMI/OCHA and non-AMI/OHCA
groups (0.19  0.25 mm2 vs. 0.32  0.62 mm2;
p ¼ 0.49).
DISCUSSION
The major ﬁndings of this OCT study evaluating
morphological characteristics of coronary artery
spasm sites in VSA patients include the following:
1) thrombus was frequently detected in patients with
VSA (28.8% of total spasm sites); 2) OCT-deﬁned
erosion, identiﬁed as the concurrence of thrombus
and intact ﬁbrous cap, was common in patients with
VSA (26%); and 3) spontaneous spasm was observed
more frequently in the AMI/OHCA group than in the
non-AMI/OHCA group.
In pathological studies, plaque erosion is deﬁned
as a loss of endothelial lining with lacerations of
the superﬁcial intimal layers in the absence of
ﬁbrous cap disruption (17). OCT imaging does not
adequately provide the resolution required to
identify and assess the endothelial lining. Taking
the limitations of OCT into account with regard to
pathological ﬁndings, we have suggested applicable
diagnostic criteria that can be used to analyze
OCT ﬁndings of spasm sites in VSA. These de-
scriptions may be helpful for future OCT studiesand to investigate the underlying pathophysiology
of VSA.
In ACS patients, plaque erosion had a lower fre-
quency of lipid plaque (43.6% vs. 100%; p < 0.001)
and thicker ﬁbrous cap (169.3  99.1 mm vs. 60.4 
16.6 mm; p < 0.001) than plaque rupture (18). In the
present study, lipid plaque was detected at 56.3% of
all spasm sites and at 55.0% of OCT-deﬁned erosion
sites. Fibrous plaque was seen at 45.0% of OCT-
deﬁned erosion sites, and mean cap thickness was
146  95 mm. The patient population and deﬁnition
FIGURE 3 Representative Case of OCT-Deﬁned Erosion
(A) Coronary angiography shows nonsigniﬁcant stenosis in mid-left anterior descending coronary artery. (B) Intracoronary ergonovine injection
resulted in complete occlusion. (C) This normalized with 200 mg of intracoronary nitroglycerin administration. (E, F) Optical coherence
tomography (OCT) revealed a red thrombus with high backscattering protrusion mass with signal-free shadowing. (D to F) An intact ﬁbrous cap
and an irregular luminal surface are visible. Asterisk indicates the total occlusion site by ergonovine provocation test and arrows indicate the
sites of OCT ﬁndings after nitroglycerine injection.
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1064of lipid plaque used were different between the
present study and the previous study of plaque
erosion (18). In the previous study, patients with
ACS were selected, and lipid plaque was deﬁned
with lipid content in $2 quadrants. In the present
study, patients with VSA were included, and even
though they had clinical manifestations of ACS, the
lipid plaque was deﬁned as lipid content in $1
quadrant. Therefore, more lipid plaque was docu-
mented in the present study using this deﬁnition. In
the present study, we found ﬁbrous cap disruption
in 4% of spasm sites, and it was not related to TCFA
or cavity in the lipid plaque. Also, non–thin-cap
disruption was the main ﬁnding of plaque disruption
seen in our VSA patients (2 of 3).
Platelet-rich white thrombus was predominantly
observed at plaque erosion sites. There was no dif-
ference in the incidence and size of thrombus at
provoked compared with spontaneous spasm sites.There was no correlation between thrombus and
clinical manifestations in this study. This may be
related to the thrombus size, which was relatively
small to cause obstruction, and may suggest that the
contact of platelets with plaque erosion may not
sufﬁce to form large thrombus. It is thought that
thrombosis that accompanies vasospasm is a result
of grossly reduced blood ﬂow secondary to critical
vascular constriction. In an animal study using
electron microscopy, a 40% to 60% reduction in
luminal diameter of the left anterior descending
coronary arteries resulted in endothelial denudation,
platelet deposition, and thrombus formation in areas
proximal to the point of maximal constriction (19).
The endothelial damage from constriction may
result in thrombus formation at the spasm site, fol-
lowed by partial or total arterial occlusion at that
site, especially if superimposed on pre-existing
arteriosclerosis.
TABLE 3 Clinical Manifestations of Fibrous Cap Disruption and OCT-Deﬁned Erosion
Patient # OCT Findings
Clinical
Manifestation
Age
(yrs)/Sex
Ergonovine
Provocation Vessel
ECG on
Admission
Braunwald
Chest Pain
Class
Smoking
Status
Peak
CK-MB
(ng/ml)
Peak
Trop-T
(ng/ml)
Area of
Thrombus
(mm2)
Maximal
Diameter of
Thrombus
(mm)
1 Fibrous cap disruption AMI 58/M  RCA ST-segment elevation – Nonsmoker 32.6 3.15 – –
2 Fibrous cap disruption AMI 50/M þ RCA ST-segment elevation – Current 192.1 3.44 0.14 0.40
3 OCT-deﬁned erosion AMI, OHCA 54/M  LAD ST-segment elevation – Current 78.0 1.53 0.03 0.28
4 OCT-deﬁned erosion AMI, OHCA 53/M  RCA ST-segment elevation – Current 491.6 4.85 0.64 1.38
5 OCT-deﬁned erosion AMI, OHCA 54/F þ RCA ST-segment elevation – Current 9.4 0.53 0.07 0.51
6 OCT-deﬁned erosion AMI 59/M  RCA ST-segment elevation – Current 11.8 0.42 0.07 0.62
7 Fibrous cap disruption UA 46/F þ LAD Normal III Nonsmoker 1.4 0.04 0.01 0.15
8 OCT-deﬁned erosion UA 59/M  LAD ST-segment depression II Nonsmoker 1.3 0.02 1.15 1.86
9 OCT-deﬁned erosion UA 45/M þ LAD T inversion III Current 0.7 0.05 2.49 2.33
10 OCT-deﬁned erosion UA 76/F  RCA T inversion II Current 0.8 0.01 0.03 0.19
11 OCT-deﬁned erosion UA 57/M þ LAD Normal III Ex-smoker 1.1 0.01 0.23 0.75
12 OCT-deﬁned erosion UA 55/M  RCA Normal II Ex-smoker 2.0 0.08 0.20 0.73
13 OCT-deﬁned erosion UA 58/M  LAD Normal III Current 0.9 0.01 0.10 0.48
14 OCT-deﬁned erosion UA 61/M þ RCA Normal I Current 2.5 0.01 0.01 0.16
15 OCT-deﬁned erosion UA 43/M þ RCA Normal III Current 1.2 0.01 0.06 0.35
16 OCT-deﬁned erosion UA 53/M þ RCA Normal III Nonsmoker 2.6 0.02 0.08 0.51
17 OCT-deﬁned erosion UA 53/M þ LAD Normal II Current 0.5 0.01 0.15 0.66
18 OCT-deﬁned erosion UA 49/M  LCx Normal III Nonsmoker NA NA 0.02 0.20
19 OCT-deﬁned erosion UA 43/M þ RCA Normal II Nonsmoker 0.6 0.02 0.03 0.24
20 OCT-deﬁned erosion UA 47/M þ LAD Normal III Nonsmoker 0.9 0.01 0.04 0.35
21 OCT-deﬁned erosion UA 51/F  LAD Normal II Nonsmoker 0.4 0.01 0.05 0.31
22 OCT-deﬁned erosion UA 43/M þ RCA Normal II Nonsmoker 0.7 0.01 0.17 1.01
23 OCT-deﬁned erosion UA 45/F þ LAD Normal III Current 0.6 0.02 0.83 0.83
24 OCT-deﬁned erosion UA 59/M þ RCA Normal I Current NA NA 0.11 0.46
F ¼ female; M ¼ male; NA ¼ not applicable; OCT ¼ optical coherence tomography; Trop-T ¼ troponin-T; other abbreviations as in Table 1.
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1065In another animal study, provoked spasm sites
showed intimal injuries (up to 60.9%) in the form
of endothelial cell protrusions, denudation, and
macrophage extravasation (20). It was suggested that
vasospasm contributed to both superﬁcial plaque
injury and actual plaque disruption (20). The inter-
action of platelets with the damaged vessel wall and
the ensuing reaction might further potentiate the
coronary spasm (9).
Previous OCT ﬁndings in ACS patients have shown
that 40% of thrombotic coronary occlusions were
caused by plaque erosion without signiﬁcant stenosis
(21). In this study, all enrolled VSA patients pre-
sented with clinical manifestations of ACS. Because
plaque erosion was a common ﬁnding in our study, it
is possible that the ACS was triggered by spasm-
related plaque erosion. ACS with nonobstructive
lesions could be amenable to treatment with anti-
platelet drugs alone, without invasive angioplasty or
coronary stent deployment, with satisfactory clinical
outcomes (21).
Although more than one-half of all spasm sites did
not have any apparent thrombus (which does not
fulﬁll the pathological deﬁnition of plaque erosion),luminal irregularity was observed in the majority of
these cases. There is a distinct possibility that lumen
irregularity in the absence of thrombus may represent
plaque erosion. There is uncertainty about the cause-
and-effect relationship between the occurrence of
vasospasm and the denudation of the endothelium,
followed by thrombus formation. In other words,
the denudation of the endothelium with or without
thrombus formation may cause vasospasm, or
repeated spasmmay have caused the current ﬁndings.
OCT was performed after the spasm provocation
test or spontaneous spasm, and therefore, it is
theoretically possible that thrombus might have been
increased or appeared with the coronary artery spasm.
The clinical beneﬁts of antiplatelet therapy in
VSA, especially aspirin, have been debated. Recent
studies have proposed the use of cilostazol for
its vasodilatory properties in the treatment of
VSA (22). In our recently published STELLA
(A Multicenter, Randomized, Double-Blind, Placebo-
Controlled, Parallel Group, Therapeutic Exploratory
Study to Evaluate the Efﬁcacy and Safety of Pletal
[Cilostazol] in Subjects With Vasospastic Angina)
trial, patients with VSA were randomized to receive
PERSPECTIVES
COMPETENCY IN MEDICAL KNOWLEDGE:
Coronary artery spasm is 1 of the causes of ACS,
including AMI and sudden cardiac death. OCT–deﬁned
erosion and thrombus are commonly observed at the
site of coronary artery spasm in patients with VSA.
TRANSLATIONAL OUTLOOK: Additional research
is needed to reveal the cause-and-effect relationship
between the occurrence of vasospasm and the
development of erosions and thrombus, and further
studies are necessary to examine the potential role of
antiplatelet therapy in VSA.
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1066cilostazol in addition to amlodipine, with signiﬁcant
improvement in angina frequency and intensity (23).
In addition to its vasodilatory properties, cilostazol
also has antiplatelet actions that may allow for the
prevention of thrombotic complications. Therefore,
further research is needed to study this agent’s an-
tiplatelet role in VSA patients.
STUDY LIMITATIONS. The ﬁndings of the present
study are based on a small cohort of patients with
angiographic evidence of coronary artery spasm. Also,
the proposed deﬁnitions using the OCT criteria in this
study are for classiﬁcation of spasm sites in conﬁrmed
VSA cases presenting with ACS; therefore, we are un-
able to broadly generalize this classiﬁcation as being
applicable to all ACS cases. In addition, because OCT
was performed only after the spasmprovocation test or
spontaneous spasm, thrombus might have increased
or appeared with the spasm. A further dedicated and
larger study to address this possibility is needed.
CONCLUSIONS
Our results show that OCT-deﬁned erosion is a com-
mon ﬁnding at the site of VSA, with accompanying
thrombus present in a substantial proportion of cases.
This ﬁnding suggests the potential role for anti-
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